OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Vepdegestrant Opens the PROTAC Era in Breast Cancer: Why Induced Proximity Matters Beyond ESR1

Vanessa Kerry։ Honored to Have Been Appointed as the Director-General's Special Envoy for Health Resilience

Benjamin L. Ebert: A Major Step Forward for Personalized Cancer Vaccines

DeLLphi-305: Durvalumab + Tarlatamab Improves Survival in First-Line ES-SCLC

Neha Vapiwala: Radiotherapy Continues to Shape Prostate Cancer Care

Oncology News, Insights, Stories by OncoDaily

VIRO 2026
Not To Miss

Highlights From VIRO 2026 – Global Voices in Renal Oncology, Day 1

ESMO
Not To Miss

ESMO Launches €1 Million Clinical Trials Funding Initiative to Support Academic Cancer Research

100 Influential Women
OncoDaily 100

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Breast Cancer ADC Trials 2026: Critical PFS–OS Gap Revealed

ESMO Launches €1 Million Clinical Trials Funding Initiative to Support Academic Cancer Research

Enrique Grande: Rethinking Bladder Preservation in Muscle-Invasive Bladder Cancer

Highlights From VIRO 2026 – Global Voices in Renal Oncology, Day 1

Dana-Farber Launches Solavia Decision Suite to Bring Cancer Treatment Expertise Into Clinical Workflow

David Tuveson Appointed Executive Director of Duke Cancer Institute

Voices
Alicia Annamalay and Lutz Hegemann

Alicia Annamalay: 25 Years of Expanding Cancer Care Access

Phoebe Ongadi: Shaping an Africa-Led Future for Cancer Research

Farina Arreguin: In Pediatric Oncology, Care Begins With Families

Shilpa Gupta: Riding to Advance Cancer Research at Cleveland Clinic

Daniel Flora: Riding 50 Miles for Cancer Research in Cincinnati

Robert Stone Named Hospital CEO of the Year – City of Hope

25 Years Expanding CML Treatment Access Worldwide – The Max Foundation

FDA Approvals
Ziihera

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

Celebrities and Cancer

OncoCalendar

World Cancer Day 2027: United by Unique

Union for International Cancer Control

04 Feb
World Cancer Day

ESSO Video-Based Workshop on Cytoreductive Surgery

European Society of Surgical Oncology

02 Feb
Cytoreductive Surgery

ESSO Webinar: Radar-Guided Precision Localisation in Melanoma and Sarcoma

European Society of Surgical Oncology

14 Oct
Cytoreductive Surgery

Lung Cancer 2026: Precision, Progress, and Practice

HonorHealth

07 Nov
Lung Cancer 2026

Oncology Nursing Summit Chicago 2026

Advanced Practice Providers Oncology Summit (APPOS)

06 Nov
Oncology Nursing Summit

Immune-oncology
Myeloid-Derived Suppressor Cells in Cancer: How MDSCs Block Immunotherapy

Myeloid-Derived Suppressor Cells in Cancer: How MDSCs Block Immunotherapy

Can 3D Ex Vivo Lymphoma Spheroids Predict Immunotherapy Response? 

RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC

Etentamig and the Next Wave of Immune Engagers in Multiple Myeloma

Dana-Farber Study Links CDK2 Activity With Response to Immune Checkpoint Blockade

Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry

What Happens If CAR T-Cell Therapy Fails? Relapse, Refractory Disease, and Next Treatment Options

Gastrointestinal-Oncology
Why Gastric Cancer Spreads Across the Abdomen: The Biology of Peritoneal Metastasis

Why Gastric Cancer Spreads Across the Abdomen: The Biology of Peritoneal Metastasis

Can Pancreatic Cancer Be Detected Early? Symptoms, Biomarkers, and New Tests

Hepatocellular Carcinoma and Viral Hepatitis: How HBV and HCV Drive Liver Cancer

Esophageal Adenocarcinoma Biomarkers: HER2, PD-L1, MSI, CLDN18.2 and Emerging Targets

Esophageal Squamous Cell Carcinoma Biomarkers: PD-L1, Molecular Features and Emerging Targets

Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

Phase 2 NEST Trial: Neoadjuvant BOT/BAL in Localized Colon Cancer

Breast-Oncology
breast cancer

Breast Cancer ADC Trials 2026: Critical PFS–OS Gap Revealed

Vepdegestrant Opens the PROTAC Era in Breast Cancer: Why Induced Proximity Matters Beyond ESR1

Anbenitamab Plus HB1801 Improves Pathologic Complete Response in HER2-Positive Early Breast Cancer

Breast Cancer Treatment Sequencing 2026: Powerful New Insights for Better Outcomes

Camizestrant and ctDNA-Guided Treatment Switching: A New Paradigm in ESR1-Mutant Advanced Breast Cancer

FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer

Stage I TNBC Is Not One Risk Group: Can Immune Biology Identify Patients Who Need Less Treatment?

Lung-Oncology
DeLLphi-305

DeLLphi-305: Durvalumab + Tarlatamab Improves Survival in First-Line ES-SCLC

Sevabertinib Moves Into First-Line HER2-Mutant NSCLC With FDA Accelerated Approval

FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer

Targeted Therapy in Advanced NSCLC: From Driver Matching to Adaptive Precision Oncology

Durvalumab Plus Tarlatamab Improves Overall Survival in First-Line Extensive-Stage Small Cell Lung Cancer

Stage III NSCLC Management 2026: Powerful Advances Transforming Multimodal Care

Pulmonary Nodules in 2026: A Risk-Based Approach to Surveillance, Biopsy, and Definitive Treatment

OncoDaily TV
Christian Ntizimira

Continue to be human: Christian Ntizimira

Stephanie Kauffman

She Left Hollywood To Fight Cancer: Stephanie Kauffman

pablo allard

Childhood Cancer Survivor Who Changed the Law: Pablo Allard’s Advocacy Journey

Cancer Care

Personalizing Colorectal Cancer Care with ctDNA? Dr. Robert Lentz

Priti Patnaik, Independent journalism

Independent journalism in global health: Priti Patnaik

Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Cancer in Women

Cancer in Women As a Global Health and Economic Issue: Dr. Maira Caleffi

oncoffee, palliative

ONCOFFEE: Colorectal Cancer, Palliative Care, and the Human Side of Oncology: Santiago Fontes

Empowering Oncologists

Empowering Oncologists: How Policy impacts Medicine?

WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Current Landscape

The Current Landscape and Future of CAR-T in Aggressive B-Cell Lymphoma

Experts by Experience

Experts by Experience with Carmen Monge

Not To Miss
Cancer Research

Top 10 Cancer Research Grants Open This Fall

ESMO Launches €1 Million Clinical Trials Funding Initiative to Support Academic Cancer Research

Highlights From VIRO 2026 – Global Voices in Renal Oncology, Day 1

Dana-Farber Launches Solavia Decision Suite to Bring Cancer Treatment Expertise Into Clinical Workflow

Agenus to Present 3-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026

FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer

Joe Biden Raises Prostate Cancer Awareness, Urges Men to Discuss Screening With Their Doctors

OncoGrants
Translation of Technologies

NIH Academic–Industrial Partnerships for Translation of Technologies R01 Grant 2026

Independence K99/R00 Award

NCI Pathway to Independence K99/R00 Award 2026

CDMRP

CDMRP Breast Cancer Clinical Research Extension Award 2026

MD Young Investigator Award

MOASC Cary Presant, MD Young Investigator Award 2027

Excellence Mobility Programme

OECI Excellence Mobility Programme 2026 for Young Oncology Professionals

Osteosarcoma Research Grant

MIB Agents OutSmarting Osteosarcoma Research Grants 2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Giuseppe Curigliano

Giuseppe Curigliano

Oncologists Location Milan, Italy
Dilyara Kaidarova

Dilyara Kaidarova

Oncologists Location Almaty, Kazakhstan
Rachna Shroff

Rachna Shroff

Oncologists Location Tucson, USA
Herdee Gloriane C. Luna

Herdee Gloriane C. Luna

Oncologists Location Quezon City, Philippines
Sara Lonardi

Sara Lonardi

Oncologists Location Padua, Italy
Maria T. Bourlon, MD, MSc, FASCO

María Teresa Bourlon

Oncologists Location Mexico City, Mexico
Shui Yen Soh

Shui Yen Soh

Oncologists Location Singapore, Singapore
Verna Vanderpuye

Verna Vanderpuye

Oncologists Location Accra, Ghana

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Bibek Aryal

Bibek Aryal: Introducing the Value Cube for Global Oncology

Enrique Grande

Enrique Grande: Rethinking Bladder Preservation in Muscle-Invasive Bladder Cancer

Salman Punekar

Salman Punekar: Daraxonrasib Marks a New Era for RAS-Mutated Lung Cancer

Sacrococcygeal Teratomas

New Paper Alert: Multidisciplinary Management of Altman Type III Sacrococcygeal Teratomas in Benin

Jithma Abeykoon

Jithma Abeykoon: NGS Profiling Is Essential for All Rosai-Dorfman Disease Tumors

Jasmin Hundal

Jasmin Hundal: New Study Reveals Breast Cancer Disparities Among South Asian American Women

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts